Lipoatrophic Diabetes Mellitus

Subscribe to Selected New Research on Lipoatrophic Diabetes Mellitus

8 relevant articles (1 outcomes, 2 trials/studies) found for this Disease

Description: A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and LIPODYSTROPHY. The latter may be generalized, partial, acquired, or congenital (LIPODYSTROPHY, CONGENITAL GENERALIZED).

Also Known As:

Diabetes Mellitus, Lipoatrophic

Relationship Network

Disease Context: Research Results

Nutritional and Metabolic Diseases

Metabolic Diseases: 1264

Glucose Metabolism Disorders: 39

Diabetes Mellitus: 22586

Type 2 Diabetes Mellitus: 11516

Lipoatrophic Diabetes Mellitus: 8

Endocrine System Diseases: 390

Diabetes Mellitus: 22586

Type 2 Diabetes Mellitus: 11516

Lipoatrophic Diabetes Mellitus: 8

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY)
2.	Syndrome
3.	Insulin Resistance
4.	Diabetes Mellitus
4 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lipoatrophic Diabetes Mellitus:

1.	Glucose (Dextrose)FDA LinkGeneric 03/01/1997 - "Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis?" Get all the results and reference details, order at left...
2.	BezafibrateIBA 03/01/1997 - "Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis?" Get all the results and reference details, order at left...
3.	AntibodiesIBA 01/01/1998 - "In an effort to identify the pathogenetic mechanisms of lipoatrophic diabetes mellitus in this patient and to develop a therapeutic strategy, antibodies against different tissues and endocrinologic regulation were investigated" 07/01/2000 - "AIMS: This study investigated the association between glutamic acid decarboxylase antibodies (GAD-AB) and Type 1, Type 2, pancreatic and lipoatrophic diabetes mellitus (DM) in South African patients" Get all the results and reference details, order at left...
4.	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/01/2000 - "AIMS: This study investigated the association between glutamic acid decarboxylase antibodies (GAD-AB) and Type 1, Type 2, pancreatic and lipoatrophic diabetes mellitus (DM) in South African patients" Get all the results and reference details, order at left...
5.	insulin receptor substrate-1 proteinIBA 11/01/1997 - "Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects." Get all the results and reference details, order at left...
6.	hydroquinone (Black and White)FDA Link 11/01/1997 - "Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects." Get all the results and reference details, order at left...
7.	Insulin (Novolin)FDA Link 12/01/1998 - "Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion." 11/01/1990 - "Lipoatrophic diabetes mellitus is a rare syndrome characterized by lipoatrophy and insulin-resistant diabetes mellitus" 11/01/2001 - "We screened for mutations in the gene of insulin-sensitive phosphodiesterase 3B (PDE3B), which regulates antilipolytic actions of insulin via reduction of intracellular cyclic AMP levels, in Japanese patients with type 2 diabetes mellitus and lipoatrophic diabetes mellitus using single-stranded conformation polymorphism analysis and Southern analysis and investigated frequencies of variable number of tandem repeats" 12/01/1988 - "To determine the role of genetic defects in the insulin receptor in the insulin resistance of lipoatrophic diabetes mellitus, we studied insulin binding, insulin receptor autophosphorylation, and insulin receptor mRNA levels and performed Southern blot analysis of genomic DNA in four siblings, all of whom have some degree of insulin resistance and three of whom have lipoatrophy" Get all the results and reference details, order at left...
8.	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 11/01/2001 - "We screened for mutations in the gene of insulin-sensitive phosphodiesterase 3B (PDE3B), which regulates antilipolytic actions of insulin via reduction of intracellular cyclic AMP levels, in Japanese patients with type 2 diabetes mellitus and lipoatrophic diabetes mellitus using single-stranded conformation polymorphism analysis and Southern analysis and investigated frequencies of variable number of tandem repeats" Get all the results and reference details, order at left...
9.	Somatomedins (Somatomedin)IBA 01/01/1998 - "Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes." Get all the results and reference details, order at left...
10.	Messenger RNA (mRNA)IBA 12/01/1988 - "To determine the role of genetic defects in the insulin receptor in the insulin resistance of lipoatrophic diabetes mellitus, we studied insulin binding, insulin receptor autophosphorylation, and insulin receptor mRNA levels and performed Southern blot analysis of genomic DNA in four siblings, all of whom have some degree of insulin resistance and three of whom have lipoatrophy" Get all the results and reference details, order at left...
14 Drugs and Important Bio-Agents and 8 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>